Hematologic malignacies Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Acute myeloid leukemia |
12/12 (100%) | RT-PCR | 16112646 | |
Chronic myeloid leukemia |
6/6 (100%) | RT-PCR | ||
Normal donor |
8/8 (100%) | RT-PCR | ||
Myeloma |
Newly diagnosed patient | 320/320 (100%) | Microarray | 21738656 |
Myeloma |
Relapse patient | 263/264 (100%) | Microarray |
Breast cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Breast carcinoma |
88/100 (88%) | RT-PCR | 19190149 |
Gynecological cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Cervical carcinoma |
54/66 (82%) | RT-PCR | 19326449 |
Ovarian cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Clear-cell carcinoma |
1/1 (100%) | RT-PCR | 17332284 | |
Mucinous ovarian carcinoma |
2/2 (100%) | RT-PCR | ||
Serous ovarian adenocarcinoma |
15/17 (88%) | RT-PCR |
Origin tissue | Cell Line ID | Frequency | Methodology | PMID |
---|---|---|---|---|
Cervical carcinoma | HeLa | RT-PCR | 16112646 | |
Hepatoma | HepG1 | RT-PCR | 16112646 | |
Leukemia | HL60 KG1 CEM-VLB Jurkat K562 P39 NB4 |
RT-PCR | 16112646 | |
Lung carcinoma-NSCLC | H1299 | RT-PCR | 16112646 | |
Lymphoma | U937 Karpas LY1 LY8 |
RT-PCR | 16112646 | |
Prostate carcinoma | DU145 | RT-PCR | 16112646 | |
Tongue carcinoma | Hn5 | RT-PCR | 16112646 |
2005-2009© CT Antigens Database